157 related articles for article (PubMed ID: 19331662)
21. Metastasis is promoted by a bioenergetic switch: new targets for progressive renal cell cancer.
Langbein S; Frederiks WM; zur Hausen A; Popa J; Lehmann J; Weiss C; Alken P; Coy JF
Int J Cancer; 2008 Jun; 122(11):2422-8. PubMed ID: 18302154
[TBL] [Abstract][Full Text] [Related]
22. TKTL1 Knockdown Impairs Hypoxia-Induced Glucose-6-phosphate Dehydrogenase and Glyceraldehyde-3-phosphate Dehydrogenase Overexpression.
Baptista I; Karakitsou E; Cazier JB; Günther UL; Marin S; Cascante M
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408935
[TBL] [Abstract][Full Text] [Related]
23. TKTL1 modulates the response of paclitaxel-resistant human ovarian cancer cells to paclitaxel.
Zheng X; Li H
Biochem Biophys Res Commun; 2018 Sep; 503(2):572-579. PubMed ID: 29885837
[TBL] [Abstract][Full Text] [Related]
24. Expression of the mutated transketolase TKTL1, a molecular marker in gastric cancer.
Staiger WI; Coy JF; Grobholz R; Hofheinz RD; Lukan N; Post S; Schwarzbach MH; Willeke F
Oncol Rep; 2006 Oct; 16(4):657-61. PubMed ID: 16969476
[TBL] [Abstract][Full Text] [Related]
25. Lack of transketolase-like (TKTL) 1 aggravates murine experimental colitis.
Bentz S; Pesch T; Wolfram L; de Vallière C; Leucht K; Fried M; Coy JF; Hausmann M; Rogler G
Am J Physiol Gastrointest Liver Physiol; 2011 Apr; 300(4):G598-607. PubMed ID: 21233279
[TBL] [Abstract][Full Text] [Related]
26. TKTL1 promotes cell proliferation and metastasis in esophageal squamous cell carcinoma.
Li J; Zhu SC; Li SG; Zhao Y; Xu JR; Song CY
Biomed Pharmacother; 2015 Aug; 74():71-6. PubMed ID: 26349965
[TBL] [Abstract][Full Text] [Related]
27. Knockdown of TKTL1 additively complements cisplatin-induced cytotoxicity in nasopharyngeal carcinoma cells by regulating the levels of NADPH and ribose-5-phosphate.
Dong Y; Wang M
Biomed Pharmacother; 2017 Jan; 85():672-678. PubMed ID: 27916418
[TBL] [Abstract][Full Text] [Related]
28. Expression patterns and prognostic role of transketolase-like 1 in muscle-invasive bladder cancer.
Semilia M; Hennenlotter J; Pavone C; Bischoff T; Kühs U; Gakis G; Bedke J; Stenzl A; Schwentner C; Todenhöfer T
World J Urol; 2015 Oct; 33(10):1403-9. PubMed ID: 25572961
[TBL] [Abstract][Full Text] [Related]
29. Transketolase protein TKTL1 overexpression: A potential biomarker and therapeutic target in breast cancer.
Földi M; Stickeler E; Bau L; Kretz O; Watermann D; Gitsch G; Kayser G; Zur Hausen A; Coy JF
Oncol Rep; 2007 Apr; 17(4):841-5. PubMed ID: 17342325
[TBL] [Abstract][Full Text] [Related]
30. A review on research progress of transketolase.
Zhao J; Zhong CJ
Neurosci Bull; 2009 Apr; 25(2):94-9. PubMed ID: 19290028
[TBL] [Abstract][Full Text] [Related]
31. Identification of transketolase as a target of PARIS in substantia nigra.
Kim H; Kang H; Lee Y; Park CH; Jo A; Khang R; Shin JH
Biochem Biophys Res Commun; 2017 Nov; 493(2):1050-1056. PubMed ID: 28939041
[TBL] [Abstract][Full Text] [Related]
32. Mechanical insights of oxythiamine compound as potent inhibitor for human transketolase-like protein 1 (TKTL1 protein).
Mariadasse R; Biswal J; Jayaprakash P; Rao GR; Choubey SK; Rajendran S; Jeyakanthan J
J Recept Signal Transduct Res; 2016; 36(3):233-42. PubMed ID: 26481897
[TBL] [Abstract][Full Text] [Related]
33. Novel transketolase inhibitor oroxylin A suppresses the non-oxidative pentose phosphate pathway and hepatocellular carcinoma tumour growth in mice and patient-derived organoids.
Jia D; Liu C; Zhu Z; Cao Y; Wen W; Hong Z; Liu Y; Liu E; Chen L; Chen C; Gu Y; Jiao B; Chai Y; Wang HY; Fu J; Chen X
Clin Transl Med; 2022 Nov; 12(11):e1095. PubMed ID: 36314067
[TBL] [Abstract][Full Text] [Related]
34. TKTL1 expression in human malign and benign cell lines.
Kämmerer U; Gires O; Pfetzer N; Wiegering A; Klement RJ; Otto C
BMC Cancer; 2015 Jun; 15():2. PubMed ID: 26187043
[TBL] [Abstract][Full Text] [Related]
35. Transketolase promotes colorectal cancer metastasis through regulating AKT phosphorylation.
Li M; Zhao X; Yong H; Xu J; Qu P; Qiao S; Hou P; Li Z; Chu S; Zheng J; Bai J
Cell Death Dis; 2022 Feb; 13(2):99. PubMed ID: 35110545
[TBL] [Abstract][Full Text] [Related]
36. Is transketolase-like protein, TKTL1, transketolase?
Meshalkina LE; Drutsa VL; Koroleva ON; Solovjeva ON; Kochetov GA
Biochim Biophys Acta; 2013 Mar; 1832(3):387-90. PubMed ID: 23261987
[TBL] [Abstract][Full Text] [Related]
37. CircDUSP16 Contributes to Cell Development in Esophageal Squamous Cell Carcinoma by Regulating miR-497-5p/TKTL1 Axis.
Ma L; Li H; Lin Y; Wang G; Xu Q; Chen Y; Xiao K; Rao X
J Surg Res; 2021 Apr; 260():64-75. PubMed ID: 33326930
[TBL] [Abstract][Full Text] [Related]
38. Mutations in the transketolase-like gene TKTL1: clinical implications for neurodegenerative diseases, diabetes and cancer.
Coy JF; Dressler D; Wilde J; Schubert P
Clin Lab; 2005; 51(5-6):257-73. PubMed ID: 15991799
[TBL] [Abstract][Full Text] [Related]
39. Transketolase counteracts oxidative stress to drive cancer development.
Xu IM; Lai RK; Lin SH; Tse AP; Chiu DK; Koh HY; Law CT; Wong CM; Cai Z; Wong CC; Ng IO
Proc Natl Acad Sci U S A; 2016 Feb; 113(6):E725-34. PubMed ID: 26811478
[TBL] [Abstract][Full Text] [Related]
40. Transketolase is upregulated in metastatic peritoneal implants and promotes ovarian cancer cell proliferation.
Ricciardelli C; Lokman NA; Cheruvu S; Tan IA; Ween MP; Pyragius CE; Ruszkiewicz A; Hoffmann P; Oehler MK
Clin Exp Metastasis; 2015 Jun; 32(5):441-55. PubMed ID: 25895698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
